SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp. engages in the design, manufacture, and launch of rockets and spacecrafts. It provides satellite communication services. The company was founded by Elon Reeve Musk on March 14, 2002 and is headquartered in Hawthorne, CA.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

The highly anticipated SpaceX IPO has arrived, driving massive investor interest and causing significant trading platform strain as market participants debate its astronomical valuation and long-term potential. While early demand remains intense, the community is deeply divided between those betting on Musk's ecosystem and others warning of a potential pump-and-dump scenario.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently seeing significant volatility and institutional attention as the broader space sector rotates ahead of the historic SpaceX IPO. Investors are actively debating whether to consolidate positions into the SpaceX narrative leader or hold core proxies like Rocket Lab, which recently benefited from inclusion in the Nasdaq-100 index.

EchoStar Corp. engages in the design, development, and distribution of digital set-top boxes and products for direct-to-home satellite service providers. It operates through the following business segments: Pay-TV, Retail Wireless, and Broadband and Satellite Services. The Pay-TV segment business strategy is to be the best provider of video services in the United States by providing products with the best technology, outstanding customer service, and great value. The Retail Wireless segment offers Retail Wireless services as well as a competitive portfolio of wireless devices. The Broadband and Satellite Services segment business strategy is to maintain and improve leadership position and competitive advantage through development of technologies and services marketed to selected sectors within the consumer, enterprise and government markets globally. The company was founded by Charlie William Ergen, Candy Ergen, and James DeFranco in 1980 and is headquartered in Englewood, CO.

EchoStar Corp - Ordinary Shares - Class A

EchoStar Corp

EchoStar is trending as investors aggressively rotate into the stock as a primary proxy for the upcoming SpaceX IPO, viewing its multi-billion dollar equity stake in the space leader as significantly undervalued relative to current market cap. The community is actively debating the stock's potential for a major short squeeze and re-rating as market participants attempt to gain exposure to the IPO's momentum.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing intense trading activity as retail and institutional investors clash over its parabolic ascent, with many monitoring the stock for potential exhaustion while others point to sustained demand for memory hardware as a primary driver. Market sentiment remains highly polarized, as community participants debate whether the price action reflects fundamental strength or an unsustainable speculative bubble.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors digest mixed signals from monthly prescription tracking data versus actual revenue recognition, leading to high volatility and speculation regarding near-term catalysts like European regulatory approvals and partnership announcements. The community remains deeply divided between long-term shareholders bullish on the pipeline and commercial rollout, and those frustrated by the lack of direct management communication and the aggressive price fluctuations.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending due to its official inclusion in the Nasdaq-100 index, a catalyst driving anticipation of significant passive institutional inflows. While investors debate the impact of high-beta AI infrastructure growth and recent debt financing, sentiment remains polarized by ongoing insider selling and the stock's significant volatility compared to its peers.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending as investors weigh its unique direct-to-device technology against the market-wide liquidity rotation triggered by the high-profile SpaceX IPO. Community sentiment remains polarized, with bullish long-term investors pointing to upcoming satellite launches and major carrier partnerships as key catalysts, while bears focus on sector volatility and concerns regarding the company's capital-intensive growth strategy.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing significant selling pressure as investors weigh strong earnings and share buybacks against the sudden departure of the CFO and broader concerns regarding the long-term impact of AI on its software model. The community remains deeply divided, with some viewing the drop as a generational buying opportunity while others fear the company is a declining value trap losing ground to AI competitors.

Tema ETF Trust - Tema Space Innovators ETF

Tema Space Innovators ETF

The Tema Space Innovators ETF is experiencing high volatility as investors position themselves ahead of the SpaceX IPO, with the community actively debating whether the ETF serves as a strategic play for private-market exposure or if it faces significant downside risk from sector-wide liquidity shifts. While some traders view the current price action as a shakeout meant to flush out retail positions before a potential rally, others express caution, highlighting concerns about potential valuation premiums and the impact of broader market volatility on space-related holdings.

Entrepreneurshares Series Trust - ERShares Private-Public Crossover ETF

Investors are flocking to XOVR as a rare, liquid vehicle to gain exposure to SpaceX through its significant pre-IPO stake, fueling intense debate regarding its valuation compared to peers. Community sentiment is divided, with many actively accumulating shares in anticipation of a potential valuation surge, while others express frustration over its sideways price action and opaque private asset pricing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

All You Need to Know About Aptevo Therapeutics (APVO) Rating Upgrade to Buy

Aptevo Therapeutics (APVO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Aptevo Therapeutics (APVO) Upgraded to Buy: Here's Why

Why Aptevo Therapeutics Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Aptevo Therapeutics Stock Slumps To All-Time Low On Reverse Split Approval

Equity

The move will cut Aptevo’s issued and outstanding shares from about 18 million to roughly a million.

What's Going On With Aptevo Therapeutics Stock Today?

Shares of Aptevo Therapeutics are trading lower Friday after the Seattle-based company announced a one-for-eighteen reverse stock split.read more...

Aptevo Therapeutics (APVO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Aptevo Therapeutics (APVO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Aptevo Therapeutics Stock Rallies On 100% Remission Rate In Acute Myeloid Leukemia Trial Cohort

The company stated that the 100% remission rate achieved at the highest dose level of the trial demonstrated the drug’s potential to redefine the frontline treatment landscape for newly diagnosed AML patients who are unfit for intensive chemotherapy.

Aptevo Stock Rises On $2.1M Registered Direct Offering, Warrant Sale: Retail  Sentiment Touches Year-High

The company said that net proceeds from the offering will be used for the continued clinical development of product candidates, as working capital, and for other general corporate purposes.

Aptevo Therapeutics Stock Draws Retail Attention After Leukemia Trial Data: Retail Extremely Bullish

The company announced that all patients with acute myeloid leukemia treated with its lead candidate, mipletamig, achieved remission within 30 days in a Phase 1b trial.

Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527, and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology. The ADAPTIR and ADAPTIR-FLEX are capable of generating differentiated bispecific and multi-specific antibodies with potentially unique mechanisms of action for the treatment of different types of cancer. The company was founded in February 2016 and is headquartered in Seattle, WA.

APVOAptevo Therapeutics Inc

Fundamentals

Feed

News

Sentiment

Fundamentals

Info

Latest APVO News